RT Journal Article
SR Electronic
T1 Progressive pigmentary purpura related to raloxifene
JF Saudi Medical Journal
JO Saudi Med J
FD Prince Sultan Military Medical City
SP 314
OP 316
VO 26
IS 2
A1 Erbagci, Zulal
A1 Tuncel, Almila
A1 Erkilic, Suna
A1 Ozkur, Mehtap
YR 2005
UL http://smj.org.sa/content/26/2/314.abstract
AB Progressive pigmentary purpura is a rare condition characterized by lymphocytic capillaritis histologically causing various clinical entities which are also named as persistent pigmented purpuric dermatoses. It is generally idiopathic; however, rare cases secondary to drugs and various diseases have been reported. In this report we describe a case of progressive pigmentary purpura induced by raloxifene, a selective estrogen receptor modulator which is primarily used in the treatment and prevention of postmenopausal osteoporosis. As far as we know, no case of progressive pigmentary purpura has previously been reported as an adverse effect of raloxifene.